Trends in melanoma in the elderly in Denmark, 1980-2012. (Q38918842)

7 September 2017

Trends in melanoma in the elderly in Denmark, 1980-2012. (English)

1 reference

7 September 2017

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785326%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Lise Hoejberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785326%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Dorte Gad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785326%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Niels Gyldenkerne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785326%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Academy of Geriatric Cancer Research (AgeCare)

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785326%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

19 January 2016

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785326%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

55 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785326%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

52-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785326%20AND%20SRC:MED&resulttype=core&format=json

Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi.

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Malignant melanoma in the elderly: different regional disease and poorer prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Trends in cancer in the elderly population in Denmark, 1980-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Regression models for relative survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Skin cancers in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Age as a prognostic factor in patients with localized melanoma and regional metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987-2009: a registry-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1114677

10.3109/0284186X.2015.1114677

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26785326%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference